149 related articles for article (PubMed ID: 34036899)
1. Cell type-specific YAP1-WWTR1/TAZ transcriptional responses after autophagy perturbations are determined by levels of α-catenins (CTNNA1 and CTNNA3).
Pavel M; Park SJ; Tanasa R; Rubinsztein DC
Autophagy; 2021 Jul; 17(7):1788-1790. PubMed ID: 34036899
[TBL] [Abstract][Full Text] [Related]
2. Increased
Park SJ; Frake RA; Rubinsztein DC
Autophagy; 2023 Mar; 19(3):943-944. PubMed ID: 35822241
[TBL] [Abstract][Full Text] [Related]
3. α-Catenin levels determine direction of YAP/TAZ response to autophagy perturbation.
Pavel M; Park SJ; Frake RA; Son SM; Manni MM; Bento CF; Renna M; Ricketts T; Menzies FM; Tanasa R; Rubinsztein DC
Nat Commun; 2021 Mar; 12(1):1703. PubMed ID: 33731717
[TBL] [Abstract][Full Text] [Related]
4. The Hippo effector TAZ (WWTR1) transforms myoblasts and TAZ abundance is associated with reduced survival in embryonal rhabdomyosarcoma.
Mohamed A; Sun C; De Mello V; Selfe J; Missiaglia E; Shipley J; Murray GI; Zammit PS; Wackerhage H
J Pathol; 2016 Sep; 240(1):3-14. PubMed ID: 27184927
[TBL] [Abstract][Full Text] [Related]
5. Loss of
Goto H; Nishio M; To Y; Oishi T; Miyachi Y; Maehama T; Nishina H; Akiyama H; Mak TW; Makii Y; Saito T; Yasoda A; Tsumaki N; Suzuki A
Development; 2018 Mar; 145(6):. PubMed ID: 29511023
[TBL] [Abstract][Full Text] [Related]
6. Recurrent WWTR1 S89W mutations and Hippo pathway deregulation in clear cell carcinomas of the cervix.
Kim SH; Basili T; Dopeso H; Da Cruz Paula A; Bi R; Issa Bhaloo S; Pareja F; Li Q; da Silva EM; Zhu Y; Hoang T; Selenica P; Murali R; Chan E; Wu M; Derakhshan F; Maroldi A; Hanlon E; Ferreira CG; Lapa E Silva JR; Abu-Rustum NR; Zamarin D; Chandarlapaty S; Matrai C; Yoon JY; Reis-Filho JS; Park KJ; Weigelt B
J Pathol; 2022 Aug; 257(5):635-649. PubMed ID: 35411948
[TBL] [Abstract][Full Text] [Related]
7. Hippo pathway effectors YAP1/TAZ induce an EWS-FLI1-opposing gene signature and associate with disease progression in Ewing sarcoma.
Rodríguez-Núñez P; Romero-Pérez L; Amaral AT; Puerto-Camacho P; Jordán C; Marcilla D; Grünewald TG; Alonso J; de Alava E; Díaz-Martín J
J Pathol; 2020 Apr; 250(4):374-386. PubMed ID: 31880317
[TBL] [Abstract][Full Text] [Related]
8. Differential influence of YAP1 and TAZ on differentiation of intestinal epithelial cell: A review.
Fallah S; Beaulieu JF
Anat Rec (Hoboken); 2023 May; 306(5):1054-1061. PubMed ID: 35648375
[TBL] [Abstract][Full Text] [Related]
9. The Hippo Pathway as Drug Targets in Cancer Therapy and Regenerative Medicine.
Nagashima S; Bao Y; Hata Y
Curr Drug Targets; 2017; 18(4):447-454. PubMed ID: 26758663
[TBL] [Abstract][Full Text] [Related]
10. Zebrafish mutants and TEAD reporters reveal essential functions for Yap and Taz in posterior cardinal vein development.
Astone M; Lai JKH; Dupont S; Stainier DYR; Argenton F; Vettori A
Sci Rep; 2018 Jul; 8(1):10189. PubMed ID: 29976931
[TBL] [Abstract][Full Text] [Related]
11.
Vázquez-Marín J; Gutiérrez-Triana JA; Almuedo-Castillo M; Buono L; Gómez-Skarmeta JL; Mateo JL; Wittbrodt J; Martínez-Morales JR
Development; 2019 Jun; 146(13):. PubMed ID: 31142542
[TBL] [Abstract][Full Text] [Related]
12. TAZ and YAP are frequently activated oncoproteins in sarcomas.
Fullenkamp CA; Hall SL; Jaber OI; Pakalniskis BL; Savage EC; Savage JM; Ofori-Amanfo GK; Lambertz AM; Ivins SD; Stipp CS; Miller BJ; Milhem MM; Tanas MR
Oncotarget; 2016 May; 7(21):30094-108. PubMed ID: 27129148
[TBL] [Abstract][Full Text] [Related]
13. The complexity of biological control systems: An autophagy case study.
Pavel M; Tanasa R; Park SJ; Rubinsztein DC
Bioessays; 2022 Mar; 44(3):e2100224. PubMed ID: 35032045
[TBL] [Abstract][Full Text] [Related]
14. The N-terminal phosphodegron targets TAZ/WWTR1 protein for SCFβ-TrCP-dependent degradation in response to phosphatidylinositol 3-kinase inhibition.
Huang W; Lv X; Liu C; Zha Z; Zhang H; Jiang Y; Xiong Y; Lei QY; Guan KL
J Biol Chem; 2012 Jul; 287(31):26245-53. PubMed ID: 22692215
[TBL] [Abstract][Full Text] [Related]
15. An optogenetic method for interrogating YAP1 and TAZ nuclear-cytoplasmic shuttling.
Dowbaj AM; Jenkins RP; Williamson D; Heddleston JM; Ciccarelli A; Fallesen T; Hahn KM; O'Dea RD; King JR; Montagner M; Sahai E
J Cell Sci; 2021 Jul; 134(13):. PubMed ID: 34060624
[TBL] [Abstract][Full Text] [Related]
16. Generation of a WWTR1 mutation induced pluripotent stem cell line, MUSIi012-A-1, using CRISPR/Cas9.
Lorthongpanich C; Jiamvoraphong N; Supakun P; Damkham N; Terbto P; Waeteekul S; U-Pratya Y; Laowtammathron C; Issaragrisil S
Stem Cell Res; 2019 Dec; 41():101634. PubMed ID: 31677525
[TBL] [Abstract][Full Text] [Related]
17. The novel potent TEAD inhibitor, K-975, inhibits YAP1/TAZ-TEAD protein-protein interactions and exerts an anti-tumor effect on malignant pleural mesothelioma.
Kaneda A; Seike T; Danjo T; Nakajima T; Otsubo N; Yamaguchi D; Tsuji Y; Hamaguchi K; Yasunaga M; Nishiya Y; Suzuki M; Saito JI; Yatsunami R; Nakamura S; Sekido Y; Mori K
Am J Cancer Res; 2020; 10(12):4399-4415. PubMed ID: 33415007
[TBL] [Abstract][Full Text] [Related]
18. CSE1L promotes nuclear accumulation of transcriptional coactivator TAZ and enhances invasiveness of human cancer cells.
Nagashima S; Maruyama J; Honda K; Kondoh Y; Osada H; Nawa M; Nakahama KI; Ishigami-Yuasa M; Kagechika H; Sugimura H; Iwasa H; Arimoto-Matsuzaki K; Nishina H; Hata Y
J Biol Chem; 2021 Jul; 297(1):100803. PubMed ID: 34022224
[TBL] [Abstract][Full Text] [Related]
19. Yap1/Taz are essential for the liver development in zebrafish.
Yi X; Yu J; Ma C; Li L; Luo L; Li H; Ruan H; Huang H
Biochem Biophys Res Commun; 2018 Sep; 503(1):131-137. PubMed ID: 29859190
[TBL] [Abstract][Full Text] [Related]
20. Identification of BRCC3 and BRCA1 as Regulators of TAZ Stability and Activity.
Sberna S; Lopez-Hernandez A; Biancotto C; Motta L; Andronache A; Verhoef LGGC; Caganova M; Campaner S
Cells; 2023 Oct; 12(20):. PubMed ID: 37887275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
